{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:08:29Z","timestamp":1783901309592,"version":"3.55.0"},"reference-count":18,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The autoimmune liver disease constituent conditions include autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis and IgG-4 associated cholangitis. They remain a diagnostic challenge to the practicing physician due to their close resemblance in clinical course, and laboratory and imaging findings to the vast array of other etiologies of liver injury. We report a case of recurrent severe hepatitis of autoimmune origin in a female patient. The disease course was marked by initial onset at age 39, followed by nearly four years of remission, and a second flare with a more exaggerated severity. Systemic lupus erythematosus was initially deemed as the culprit, however formal diagnostic criteria were not fulfilled and the serological findings were not reproduced at a later date. With the aim of ascertaining the underlying process, the patient underwent an extensive array of testing with regards to infectious, genetic, systemic and autoimmune disease. Positive anti-dsDNA (double stranded DNA) and an antinuclear antibody titer of 1:160 provided the strongest support for an autoimmune etiology, specifically autoimmune hepatitis or possibly an overlap syndrome. An excellent outcome was achieved via treatment with corticosteroids, ursodeoxycholic acid and plasmapheresis.<\/jats:p>","DOI":"10.2478\/prilozi-2021-0007","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T14:05:22Z","timestamp":1619532322000},"page":"83-90","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Severe Hepatitis of Autoimmune Origin"],"prefix":"10.2478","volume":"42","author":[{"given":"Gregor","family":"Krstevski","sequence":"first","affiliation":[{"name":"University Clinic of Gastroenterohepatology , Faculty of Medicine, University Ss. Cyril and Methodius , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktorija Caloska","family":"Ivanova","sequence":"additional","affiliation":[{"name":"University Clinic of Gastroenterohepatology , Faculty of Medicine, University Ss. Cyril and Methodius , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Andreevski","sequence":"additional","affiliation":[{"name":"University Clinic of Gastroenterohepatology , Faculty of Medicine, University Ss. Cyril and Methodius , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Serafimovski","sequence":"additional","affiliation":[{"name":"Macedonian Academy of Sciences and Arts , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"2026071211373058405_j_prilozi-2021-0007_ref_001_w2aab3b7c14b1b6b1ab1ab1Aa","doi-asserted-by":"crossref","unstructured":"1. Than NN, Oo YH. A Concise Review of Autoimmune Liver Diseases. Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases. IntechOpen. 2015. DOI:10.5772\/60520.10.5772\/60520","DOI":"10.5772\/60520"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_002_w2aab3b7c14b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. Hubers LM, Wenniger LJM, Doorenspleet ME. IgG-4 Associated Cholangitis: A Comprehensive Review. Clinic Rev Allerg Immunol 2015; 48, 198\u2013206. DOI:10.1007\/s12016-014-8430-2.10.1007\/s12016-014-8430-2","DOI":"10.1007\/s12016-014-8430-2"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_003_w2aab3b7c14b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Jepsen P, Gronbaek L, Vilstrup H. Worldwide incidence of Autoimmune Liver Disease. Dig Dis 2015; 33(suppl 2):2-12. DOI:10.1159\/000440705.10.1159\/000440705","DOI":"10.1159\/000440705"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_004_w2aab3b7c14b1b6b1ab1ab4Aa","unstructured":"4. Mehta N. Drug-Induced Hepatotoxicity. Medscape 2019; https:\/\/emedicine.medscape.com\/article\/169814-overview."},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_005_w2aab3b7c14b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Talwani R, Gilliam BL, Howell, C. Infectious Diseases and the Liver. Clin Liver Dis 2011; 15(1), 111\u2013130. DOI: 10.1016\/j.cld.2010.09.002.10.1016\/j.cld.2010.09.002","DOI":"10.1016\/j.cld.2010.09.002"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_006_w2aab3b7c14b1b6b1ab1ab6Aa","unstructured":"6. Sharma B, John S. Nonalcoholic Steatohepatitis. StatPearls. Treasure Island: StatPearls Publishing 2020; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470243\/."},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_007_w2aab3b7c14b1b6b1ab1ab7Aa","unstructured":"7. Kumar A, Riley CA. Inherited Liver Diseases in Adults. West J Med 1995; 163(4), 382-386. PMCID:PMC1303145."},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_008_w2aab3b7c14b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. Shimizu, Y. Liver in systemic disease. World J Gastroenterol 2008; 14(26), 4111\u20134119. DOI: 10.3748\/wjg.14.4111.10.3748\/wjg.14.4111","DOI":"10.3748\/wjg.14.4111"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_009_w2aab3b7c14b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Weisbart RH, Colburn K. Effect of Corticosteroids on Serum Antinuclear Antibodies in Mac. Immunopharmacology. 1984. 8(2): 97\u2013101. DOI: 10.1016\/0162-3109(84)90048-1. PMID: 6334672.10.1016\/0162-3109(84)90048-1","DOI":"10.1016\/0162-3109(84)90048-1"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_010_w2aab3b7c14b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Anaya JM, Villarraga AR, Carrasco MG. The Autoimmune Tautology. Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes. Autoimmune Disease 2012; 2012. Article ID: 297193. DOI:10.1155\/2012\/297193.10.1155\/2012\/297193336280722666553","DOI":"10.1155\/2012\/297193"},{"key":"#cr-split#-2026071211373058405_j_prilozi-2021-0007_ref_011_w2aab3b7c14b1b6b1ab1ac11Aa.1","unstructured":"11. Anaya JM. The diagnosis and clinical significance of polyautoimmunity. Autoimmun Rev 2014"},{"key":"#cr-split#-2026071211373058405_j_prilozi-2021-0007_ref_011_w2aab3b7c14b1b6b1ab1ac11Aa.2","doi-asserted-by":"crossref","unstructured":"13(4-5):423-426. DOI:10.1016\/j.autrev. 2014.01.049.","DOI":"10.1016\/j.ijep.2013.12.001"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_012_w2aab3b7c14b1b6b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. Siriwardhane T, Krishna K, Ranganathan V, et al. Significance of Anti-TPO as an Early Predictive Marker in Thyroid Disease. Autoimmune Diseases 2019; 2019. Article ID: 1684074. DOI:10.1155\/2019\/1684074.10.1155\/2019\/1684074669935831467701","DOI":"10.1155\/2019\/1684074"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_013_w2aab3b7c14b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Washington M. Autoimmune liver disease: Overlap and outliers. Modern Pathology 2007; 20(suppl 1): S15-30. DOI:10.1038\/modpathol.3800684.10.1038\/modpathol.380068417486048","DOI":"10.1038\/modpathol.3800684"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_014_w2aab3b7c14b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Trivedi PJ, Hirschfield GM. Treatment of auto-immune liver disease: current and future therapeutic options. Ther Adv Chronic Dis 2013; 4(3): 119\u2013141. DOI: 10.1177\/2040622313478646.10.1177\/2040622313478646362975023634279","DOI":"10.1177\/2040622313478646"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_015_w2aab3b7c14b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Goode EC, Rushbrook SM. A review of the medical treatment of primary sclerosing cholangitis in the 21st century. Ther Adv Chronic Dis 2016; 7(1): 68\u201385. DOI: 10.1177\/2040622315605821.10.1177\/2040622315605821470742726770670","DOI":"10.1177\/2040622315605821"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_016_w2aab3b7c14b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. Maestranzi S, Przemioslo R, Mitchell H. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA. Ann Clin Biochem 1998; 35: 99\u2013103. DOI: 10.1177\/000456329803500113.10.1177\/0004563298035001139463746","DOI":"10.1177\/000456329803500113"},{"key":"2026071211373058405_j_prilozi-2021-0007_ref_017_w2aab3b7c14b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. Keklik M, Sivgin S, Kaynar L. Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: A single center experience. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis 2013; 48: 323\u2013326 DOI: 10.1016\/j.transci.2013.04.009.10.1016\/j.transci.2013.04.00923602141","DOI":"10.1016\/j.transci.2013.04.009"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2021-0007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:22:45Z","timestamp":1783898565000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2021-0007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,23]]},"published-print":{"date-parts":[[2021,4,1]]}},"alternative-id":["10.2478\/prilozi-2021-0007"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2021-0007","relation":{},"ISSN":["1857-8985","1857-9345"],"issn-type":[{"value":"1857-8985","type":"electronic"},{"value":"1857-9345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}